ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME

Title:

ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME

Document Type and Number:

WIPO Patent Application WO/2017/138710

Kind Code:

A1

Abstract:

The present invention relates to an ultraviolet-hardening hydrogel resin for transdermal administration, a hydrogel thereof, and a cataplasm agent using same, and more particularly, to a hydrogel resin, a hydrogel obtained by ultraviolet-hardening same, and a cataplasm agent containing same, wherein the hydrogel resin increases the water content in the hydrogel applied as a drug layer in the cataplasm agent, and has the optical composition and composition ratio so as to mitigate irritation to the skin, enable control of adhesion of the hydrogel resin through controlling crosslinking, as well as control of drug release and transdermal absorption.

More Like This:

WO/2020/110100	DEVICES FOR TOPICAL DELIVERY OF ACTIVE AGENTS TO A TARGET SITE
JP7421296	Adhesive sheet for body application in container
JP2009501751	Non-vomitable oral rapid disintegrating film for antiemetics or anti-migraine agents

Inventors:

CHOI YOUNG KWEON (KR)
OH YONG HO (KR)
KIM SEONG SU (KR)
HO HWAN KI (KR)
HAN SONG MI (KR)
KIM MYUNG JIN (KR)

Application Number:

PCT/KR2017/001051

Publication Date:

August 17, 2017

Filing Date:

February 01, 2017

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ICURE PHARM INC (KR)

International Classes:

A61K9/70; A61K31/167; A61K31/192; A61K31/196; A61K31/54; A61K45/06; C08J3/075; C08L101/00

Foreign References:

KR20120096675A	2012-08-31
KR20070011981A	2007-01-25
KR20140006172A	2014-01-16
KR20050078679A	2005-08-08
KR20130124504A	2013-11-14

Other References: